Most randomized controlled trials for psoriasis used placebo comparators despite the availability of effective treatments
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 133, 72-79
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion salesNature Reviews Rheumatology, 2013
- Global Epidemiology of Psoriasis: A Systematic Review of Incidence and PrevalenceJournal of Investigative Dermatology, 2013
- Lack of Head-to-head Trials and Fair Control ArmsJAMA Internal Medicine, 2012
- Comparative Effectiveness Research: Challenges for Medical JournalsPLOS Medicine, 2010
- Five Next Steps for a New National Program for Comparative-Effectiveness ResearchNew England Journal of Medicine, 2010
- The use of unequal randomisation ratios in clinical trials: A reviewContemporary Clinical Trials, 2006
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy and Therapeutics, 2002
- What Makes Placebo-Controlled Trials Unethical?The American Journal of Bioethics, 2002
- Estimating Deterministic Trends in the Presence of Serially Correlated ErrorsReview of Economics and Statistics, 1997
- Equipoise and the Ethics of Clinical ResearchNew England Journal of Medicine, 1987